Likewise, bvFTD displayed smaller thalamus and right amygdala volumes relative to ALS, indicating that thalamic involvement may be a key marker of bvFTD that is not necessarily restricted to carriers of the C9orf72 gene expansion, and may develop in ALS patients with frontal disease progression.45 This evidence concerns the gene C9orf72 and amyotrophic lateral sclerosis.